#1292ef

iRhythm Technologies

#f9f9f9

Kaja Odegard

Shawn Lewis

Allan Wilsker

Kevin King

Justin Cambra

Matthew Garrett

Kristina Kone

Ann Burdi Fantuzzi

Charles Davies

James Weidaw

Shena Park

Irina Velichko

Jeffrey Mosley

Lisa Kain

Sophy Sok

Single-use
Cardiac Monitoring
The Zio service is a complete ambulatory cardiac monitoring solution built with the patient in mind — and reinforced with clinical evidence.
Superior clinical accuracy1
Exceptional patient experience2
Lower cost of care3
2 Million
Patients analyzed 4
30+
Peer reviewed
publications 5
98%
Patient compliance 6
The heart monitor that changed the game.
We set out to do three things that had never been done before:
1
Create a user-friendly heart monitor that wouldn’t disrupt a patient’s life.
Conventional monitors are cumbersome. More often than not, patients don’t wear them for the prescribed time period.
2
Create a continuous heart monitor that could be worn for up to 14 days.
Conventional monitors can only be worn for up to 48 hours. In many cases, that’s not enough time to get a full picture of the heart.
3
Create a service that would provide continuous, accurate data unseen in the industry.
Data from conventional monitors contains a high degree of noise and interruptions. And it’s often incomplete, resulting in wasted time, costly re-testing and low physician trust.
“The monitor was so easy to use. It did all the work for me.”
Mary Sue,
Zio patient
How does the Zio Service work?
Physician prescribes a monitor, and the monitor is applied to the patient at home or in-clinic.
Patient wears the monitor and then mails it back to Zio.
Zio analyzes the data.
Physician receives a high-quality, actionable report.
Source: Clinical Publication Summary
Source: Barrett P., et al., Comparison of 24-hour Holter monitoring vs. 14-day novel adhesive patch electrocardiographic monitoring. American Heart Journal of Medicine, 2014.
Source: Health System Case Studies
Source: iRhythm Technologies, 2020. Form 10-K 2019. Retrieved from  https://investors.irhythmtech.com/sec-filings/sec-filing/10-k/0001388658-20-000034
Source:Data on file. iRhythm Technologies, 2020.
Source: Data on file. Analysis of median wear period/prescribed duration (%) of 587,872 devices from 4/1/2018 to 3/31/2019. iRhythm Technologies, 2019

The Investor Relations website contains information about iRhythm Technologies's business for stockholders, potential investors, and financial analysts.

iRhythm Technologies, Inc.